Furiex, Menarini sign licensing deal to commercialize Priligy
Presently, Priligy is marketed for on-demand treatment of premature ejaculation in 15 countries in Europe, Asia and Latin America. According to the agreement, Furiex is entitled to receive
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.